Evidence map›Paper›PMID 41866895›Full record

ArticleThe Permanente journal2026

Successful Outcome of Rhino-Orbital-Cerebral Mucormycosis With Extensive Intracranial Disease in a Patient With Poorly Controlled Diabetes.

James Dorroh, Cw David Chang, Eric Y Du, D Matthew Shoemaker, Tabitha Galloway, Carisa Petris, Sachin Patil, Mohammed Alnijoumi, Hariharan Regunath

Abstract readCase Reports
In one paragraph

Article in The Permanente journal, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

James DorrohDepartment of Medicine, Stanford University School of Medicine, Stanford, CA, USA.
Cw David ChangDepartment of Otolaryngology-Head and Neck Surgery, University of Missouri School of Medicine, Columbia, MO, USA.
Eric Y DuDepartment of Otolaryngology-Head and Neck Surgery, University of Missouri School of Medicine, Columbia, MO, USA.ORCID 0000-0002-1884-7299
D Matthew ShoemakerDivision of Infectious Diseases, University of Kansas Medical Center, Kansas City, KS, USA.
Tabitha GallowayDepartment of Otolaryngology-Head and Neck Surgery, University of Missouri School of Medicine, Columbia, MO, USA.
Carisa PetrisDepartment of Ophthalmology, University of Missouri School of Medicine, Columbia, MO, USA.
Sachin PatilPulmonary and Critical Care Medicine, Cox Health, Springfield, MO, USA.
Mohammed AlnijoumiHenry Ford Health System, Department of Medicine, Division of Pulmonary and Critical Care Medicine, Henry Ford Health, Detroit, MI, USA.
Hariharan RegunathDepartment of Medicine, Division of Infectious Diseases, University of Missouri School of Medicine, Columbia, MO, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Rhino-orbital-cerebral mucormycosis is a life-threatening infection typically requiring complete surgical debridement of necrotic tissue for survival. The authors have reported a case of invasive mucormycosis in a 22-year-old female with severe diabetic ketoacidosis and recent COVID-19 infection. The patient developed extensive intracranial disease, including cavernous sinus thrombosis and internal carotid artery occlusion, which precluded complete surgical source control without extensive morbidity. Facing such circumstance, a multidisciplinary team pursued an aggressive, individualized multimodal strategy. This included high-dose liposomal amphotericin B, targeted serial endoscopic debridements of extracranial disease, and adjunctive therapies comprising iron chelation (deferasirox), hyperbaric oxygen, and combination antifungal therapy with caspofungin and posaconazole. Despite the inability to achieve complete surgical clearance, this regimen halted disease progression and resulted in clinical and radiological regression. This case illustrated that a coordinated, multimodal approach utilizing aggressive medical management can achieve favorable outcomes in select patients with otherwise inoperable, extensive intracranial mucormycosis.

Indexed as

Brain DiseasesCOVID-19Diabetic KetoacidosisMucormycosisOrbital DiseasesAmphotericin BAntifungal AgentsCaspofunginCombined Modality TherapyDebridementDeferasiroxFemaleHumansHyperbaric OxygenationTreatment OutcomeTriazolesAmphotericin BAntifungal AgentsCaspofunginDeferasiroxliposomal amphotericin BposaconazoleTriazolesamphotericin BCOVID-19deferasiroxdiabetic ketoacidosishyperbaric oxygen therapymucormycosisposaconazole

Identifiers

PMID41866895
PMCPMC13266747

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.